Efficacy of Tranexamic Acid on Blood Loss During Percutaneous Nephrolithotomy.
NCT ID: NCT04367155
Last Updated: 2021-03-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
200 participants
INTERVENTIONAL
2019-09-01
2022-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Tranexamic Acid Use in Percutaneous Nephrolithotomy
NCT02966236
Tranexamic Acid in Percutaneous Nephrolithotomy
NCT05947435
The Effects of Tranexamic Acid or Placebo on Perioperative Bleeding in Adults Undergoing Liver Transplantation.
NCT04753151
The Effect of ACT and Tranexamic Acid on Bleeding in Cardiac Surgery
NCT06109155
A Trial of a Hospital Policy of Tranexamic Acid Use to Reduce Transfusion in Major Non-cardiac Surgery
NCT04803747
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
tranexamic acid local
tranexamic acid inside the irrigation fluid
Tranexamic acid injection
hemostatics use
tranexamic acid IV
tranexamic acid injection
Tranexamic acid injection
hemostatics use
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tranexamic acid injection
hemostatics use
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Stones ≥ 2 cm and/or mild to moderate hydronephrosis.
Exclusion Criteria
* Bilateral simultaneous PCNL
* Morbid obesity (BMI \>40)
* Refuse to complete study requirements
* Untreated UTI
* Atypical bowel interposition by CT
* Tumour in the presumptive access tract area or Potential malignant kidney tumour
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kafrelsheikh University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Diaa Eldin Taha Ramadan Mohamed
Lecturer of urology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Diaa Eldin Taha, MD
Role: PRINCIPAL_INVESTIGATOR
Lecturer of urology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kafrelsheikh faculty of medicine
Kafr ash Shaykh, Kafrelsheikh, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Cleveland B, Norling B, Wang H, Gandhi V, Price CL, Borofsky MS, Pais V, Dahm P. Tranexamic acid for percutaneous nephrolithotomy. Cochrane Database Syst Rev. 2023 Oct 26;10(10):CD015122. doi: 10.1002/14651858.CD015122.pub2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RS/19.22
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.